NLGN3 has been shown to act through the PI3K-Akt-mTOR pathway to induce synaptic gene expression, thus establishing a feed-forward loop in which increased neural activity begets increased tumor sensitivity to this activity [35]. The gene discussed is NLGN3; the disease is neoplasm.